clinical trial · NCT00216879
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
LEO Pharma·phase3·completed·n = 800
Psoriasis of ScalpCalcipotriol plus betamethasone dipropionate gel (LEO 80185)
brief summary
The purpose of the trial is to study the safety and efficacy of long term use of once daily applications, as needed, of calcipotriol plus betamethasone dipropionate gel, as compared to calcipotriol alone in the same gel. The primary response criteria will be the incidence of adverse drug reactions of any type, and the incidence of adverse events of concern associated with long-term corticosteroid use on the scalp.
started
Feb 1, 2005
primary completion
—
completion
Jul 1, 2006
last updated
Feb 24, 2025
official title
Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol